When Ghana established the National Vaccine Institute (NVI) after COVID-19, it wasn’t as regards to well being, it used to be a countrywide safety determination.

The pandemic uncovered Africa’s dependence on exterior vaccine provide, making native manufacturing no longer simply fascinating however very important for sovereignty and resilience.

In our newest Critical Analysis, IMANI examines Ghana’s evolving vaccine ecosystem and Africa’s collective push to supply 60% of its vaccine wishes by way of 2040. The research highlights:

Why executive’s $50 million seed fund and strategy assurance coverage may just make or destroy the NVI’s sustainability.

The institutional bottlenecks, from regulatory readiness to human growth, threatening Africa’s production ecosystem.

How reaching the 2040 goal will call for coordinated political will, long-term financing, and a strategic transfer past donor dependency.

“Vaccine manufacturing is not a project, it’s a test of Africa’s ability to align health policy with industrial transformation.”

Read the overall research right here:
https://imaniafrica.org/2025/11/ghanas-vaccine-manufacturing-ambition-and-africas-2040-challenge/

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by way of Readers and Contributors in this platform don’t essentially constitute the perspectives or coverage of Multimedia Group Limited.

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by way of Readers and Contributors in this platform don’t essentially constitute the perspectives or coverage of Multimedia Group Limited.